D. Levine

Thyroid abnormalities following the use of cytotoxic T‐lymphocyte antigen‐4 and programmed death receptor protein‐1 inhibitors in the treatment of melanoma

J. Larkin, M. Gore, J. Larkin, 2017, Clinical endocrinology.